Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma
Background and Objective: The most effective therapy against renal cell carcinoma (RCC) is surgical treatment; however, there have been few large-scale studies that focused on the oncological outcome of this disease in China. The aim of the current study was to report the clinicopathological results...
Saved in:
Published in | Ai zheng no. 12; pp. 995 - 999 |
---|---|
Main Author | |
Format | Journal Article |
Language | Chinese |
Published |
2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background and Objective: The most effective therapy against renal cell carcinoma (RCC) is surgical treatment; however, there have been few large-scale studies that focused on the oncological outcome of this disease in China. The aim of the current study was to report the clinicopathological results and cancer-specific survival (CSS) rate in RCC patients after surgical treatment in our center. Methods: We retrospectively analyzed the clinicopathological data of 336 RCC patients who underwent radical or partial nephrectomy between 1999 and 2006. Of the 336 patients, 226 were male and 110 were female; the median age was 51 years. Univariate and multivariate analyses were conducted to identify the independent prognostic predictors for this cohort of RCC patients. Results: During follow-up, the overall 5-year CSS rate was 81.4%. The 5-year CSS rates for patients with stage-I, -II, -III, and -IV RCC were 94.7%, 88.9%, 68.8%, and 19.3%, respectively. The patients with T1N0M0 (T1) and T2N0M0 (T2) tumors had similar |
---|---|
Bibliography: | TH774 renal cell carcinoma nephron-sparing surgery radical nephrectomy 44-1195/R prognosis Kidney; renal cell carcinoma; radical nephrectomy; nephron-sparing surgery; prognosis Kidney S858.292 |
ISSN: | 1000-467X 1944-446X |